Longbow Research Initiates Coverage on Amrize (NYSE:AMRZ)

Research analysts at Longbow Research began coverage on shares of Amrize (NYSE:AMRZ) in a research note issued to investors on Monday, Marketbeat Ratings reports. The brokerage set a “buy” rating on the stock.

Other research analysts have also issued reports about the company. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $60.00 target price on shares of Amrize in a research report on Monday, September 21st. Weiss Ratings downgraded Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. Morgan Stanley set a $63.00 price target on Amrize and gave the company an “overweight” rating in a research report on Monday, June 22nd. DA Davidson set a $40.00 price target on Amrize in a research note on Friday. Finally, UBS Group cut their price objective on Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, Amrize has a consensus rating of “Hold” and an average target price of $50.00.

Amrize Stock Performance

NYSE:AMRZ opened at $36.43 on Monday. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The company has a market cap of $20.15 billion, a P/E ratio of 16.79, a P/E/G ratio of 1.27 and a beta of 0.20. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The firm’s 50 day moving average is $41.73 and its two-hundred day moving average is $49.16.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion during the quarter. Analysts expect that Amrize will post 2.46 EPS for the current year.

Insider Buying and Selling

In related news, insider Stephen S. Clark bought 5,260 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was bought at an average price of $47.31 per share, with a total value of $248,850.60. Following the completion of the transaction, the insider directly owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. This represents a 97.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jacques Sanche bought 4,150 shares of the firm’s stock in a transaction dated Wednesday, August 26th. The stock was bought at an average cost of $45.02 per share, with a total value of $186,833.00. Following the transaction, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 48,983 shares of company stock valued at $2,158,755 over the last ninety days. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Several hedge funds have recently modified their holdings of the stock. Allied Investment Advisors LLC raised its holdings in shares of Amrize by 10.1% during the 3rd quarter. Allied Investment Advisors LLC now owns 264,812 shares of the company’s stock valued at $9,901,000 after buying an additional 24,363 shares during the period. HF Advisory Group LLC boosted its holdings in Amrize by 31.1% in the 3rd quarter. HF Advisory Group LLC now owns 27,958 shares of the company’s stock worth $1,045,000 after acquiring an additional 6,633 shares during the period. Grove Bank & Trust boosted its holdings in Amrize by 2.1% in the 3rd quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock worth $653,000 after acquiring an additional 353 shares during the period. Farther Finance Advisors LLC boosted its holdings in Amrize by 3.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock worth $542,000 after acquiring an additional 543 shares during the period. Finally, Versant Capital Management Inc boosted its holdings in Amrize by 58.9% in the 3rd quarter. Versant Capital Management Inc now owns 5,991 shares of the company’s stock worth $224,000 after acquiring an additional 2,221 shares during the period.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.